Page last updated: 2024-10-15

n(10)-methylfolate

Cross-References

ID SourceID
PubMed CID135434845
CHEMBL ID158990
CHEBI ID183928
SCHEMBL ID159228
SCHEMBL ID17292883
MeSH IDM0090919

Synonyms (44)

Synonym
(2s)-2-[[4-[(2-amino-4-hydroxy-pteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
glutamic acid, n-{p-[(2-amino-4-hydroxy-6-pteridyl-methyl)methylamino]benzoyl}-
nsc 107144
n-(p-(((2-amino-4-hydroxy-6-pteridyl)methyl)methylamino)benzoyl)glutamic acid
n(10)-methylfolate
glutamic acid, n-(p-(((2-amino-4-hydroxy-6-pteridyl)methyl)methylamino)benzoyl)-
l-glutamic acid, n-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)methylamino)benzoyl)-
glutamic acid, n-(p-(((2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl)methylamino)benzoyl)-, l-
10-methylfolic acid
nsc107144
n10-methylpteroylglutamic acid
methopterin
nsc-107144
methopterine
10-methylpteroylglutamic acid
n10-methylfolic acid
2410-93-7
CHEMBL158990 ,
CHEBI:183928
(2s)-2-[[4-[(2-amino-4-oxo-3h-pteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
bdbm50023905
2-{4-[(2-amino-4-oxo-1,4-dihydro-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(10-methylfolate)
(2s)-2-[[4-[(2-amino-4-oxo-1h-pteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
9tjy624421 ,
unii-9tjy624421
1-methylpteroylglutamic acid
methotrexate impurity c [ep impurity]
(2s)-2-((4-(((2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl)methylamino)benzoyl)amino)pentanedioic acid
methopterin [mi]
l-glutamic acid, n-(4-(((2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl)methylamino)benzoyl)-
SCHEMBL159228
SCHEMBL17292883
(2s)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoyl]amino]pentanedioic acid (n-methylfolic acid, methopterin)
(s)-2-(4-(((2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid
16136-17-7
DTXSID10936487
n-(4-{[(4-hydroxy-2-imino-1,2-dihydropteridin-6-yl)methyl](methyl)amino}benzoyl)glutamic acid
Q27273195
A899540
methotrexate impurity c
CAA41093
n-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl](methyl)amino}benzoyl)-l-glutamic acid
AKOS040744574
r6f ,
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
folic acidsA group of heterocyclic compounds based on the pteroic acid skeleton conjugated with one or more L-glutamic acid units.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Thymidylate synthaseHomo sapiens (human)Ki1.00000.00010.34353.0000AID212457
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (21)

Processvia Protein(s)Taxonomy
dTMP biosynthetic processThymidylate synthaseHomo sapiens (human)
dTTP biosynthetic processThymidylate synthaseHomo sapiens (human)
circadian rhythmThymidylate synthaseHomo sapiens (human)
response to xenobiotic stimulusThymidylate synthaseHomo sapiens (human)
response to toxic substanceThymidylate synthaseHomo sapiens (human)
negative regulation of translationThymidylate synthaseHomo sapiens (human)
uracil metabolic processThymidylate synthaseHomo sapiens (human)
methylationThymidylate synthaseHomo sapiens (human)
response to progesteroneThymidylate synthaseHomo sapiens (human)
response to vitamin AThymidylate synthaseHomo sapiens (human)
response to cytokineThymidylate synthaseHomo sapiens (human)
tetrahydrofolate interconversionThymidylate synthaseHomo sapiens (human)
response to ethanolThymidylate synthaseHomo sapiens (human)
response to organophosphorusThymidylate synthaseHomo sapiens (human)
developmental growthThymidylate synthaseHomo sapiens (human)
cartilage developmentThymidylate synthaseHomo sapiens (human)
response to glucocorticoidThymidylate synthaseHomo sapiens (human)
response to folic acidThymidylate synthaseHomo sapiens (human)
intestinal epithelial cell maturationThymidylate synthaseHomo sapiens (human)
DNA biosynthetic processThymidylate synthaseHomo sapiens (human)
liver regenerationThymidylate synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
mRNA regulatory element binding translation repressor activityThymidylate synthaseHomo sapiens (human)
thymidylate synthase activityThymidylate synthaseHomo sapiens (human)
folic acid bindingThymidylate synthaseHomo sapiens (human)
protein homodimerization activityThymidylate synthaseHomo sapiens (human)
sequence-specific mRNA bindingThymidylate synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
nucleusThymidylate synthaseHomo sapiens (human)
cytoplasmThymidylate synthaseHomo sapiens (human)
mitochondrionThymidylate synthaseHomo sapiens (human)
mitochondrial inner membraneThymidylate synthaseHomo sapiens (human)
mitochondrial matrixThymidylate synthaseHomo sapiens (human)
cytosolThymidylate synthaseHomo sapiens (human)
mitochondrionThymidylate synthaseHomo sapiens (human)
cytosolThymidylate synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID212457Inhibitory constant of thymidylate synthase was determined in human AML cells1987Journal of medicinal chemistry, Apr, Volume: 30, Issue:4
Folate analogues as inhibitors of thymidylate synthase.
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (60.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]